Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-5226
Abstract: Immune checkpoint inhibitors (ICI) targeting PD-1/PD-L1 and CTLA4 are effective treatments in multiple cancer types, but durable responses are seen only in a minority of patients. Resistance to ICI is likely to reflect a combination…
read more here.
Keywords:
il17ra;
exome wide;
cancer patients;
patients treated ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2018.00802
Abstract: The therapeutic effect of mesenchymal stem cells (MSCs) in multiple sclerosis (MS) and the experimental autoimmune encephalomyelitis (EAE) model has been well described. This effect is, in part, mediated through the inhibition of IL17-producing cells…
read more here.
Keywords:
il17ra mscs;
effect;
mscs;
cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Frontiers in Physiology"
DOI: 10.3389/fphys.2020.549656
Abstract: Histone deacetylase (HDAC) has been implicated in rheumatoid arthritis (RA) progression. We investigated the roles of histone deacetylase 3 (HDAC3) involved in RA-associated interstitial lung disease (ILD) fibrosis. Firstly, we measured the expression of HDAC3…
read more here.
Keywords:
fibrosis;
mir 19a;
histone deacetylase;
hdac3 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Biomolecules"
DOI: 10.3390/biom13030421
Abstract: The unclear etiology and pathogenesis of interstitial cystitis/bladder pain syndrome (IC/BPS) are responsible for the lack of effective treatment and the poor patient prognosis. Various studies show that chronic inflammation and immune responses are important…
read more here.
Keywords:
il17ra;
cystitis bladder;
bps;
bladder pain ... See more keywords